Class action spells trouble for Slater & Gordon Limited shares

Slater & Gordon Limited (ASX:SGH) is facing a class action from Maurice Blackburn.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Tort law practitioner and class action specialist Slater & Gordon Limited (ASX: SGH) is facing a taste of its own medicine with rival law firm Maurice Blackburn likely scrubbed off the Christmas card list after it announced a proposed class action targeting Slater & Gordon.

Ever since late June when Slater & Gordon conceded that its accounting practices were under investigation by ASIC buying its shares with client money would probably mean a one-way bus ticket to Centrelink for professional fund managers, although plenty have been left red faced after taking part in an institutional capital raising at $6.37 per share worth $608 million to fund the prior purchase of the UK claims management division of Quindell PLC.

Retail investors also paid $6.37 a share to make up the balance of the $890 million raised, with Slater & Gordon valuing the business it was buying at $1.225 billion.

If the law firm were proven negligent in its due diligence or full disclosure obligations around risks on the Quindell acquisition for example a class action could spell disaster, although that's a big if and it's much more likely Maurice Blackburn is looking at the profit downgrade issued on December 17 only weeks after Slater & Gordon twice confirmed to investors it expected to meet 2016's guidance for EBITDAW of $205 million.

Slater & Gordon also confirmed it expected to meet 2016 guidance at its August 28 2015 full year results meeting, which is another reported target point for Maurice Blackburn and means the class action has potentially many more members and a higher claim for compensation given Slater's share price closed at $3.12 on that date.

In a class action over the profit downgrade Maurice Blackburn would seek retail investors who bought shares after the confirmation guidance of November 20 or August 28 only to incur losses afterwards as the law firm retracted that guidance on December 17.

On November 20 shares closed at $2.68 and now trade for around 95 cents, eligible shareholders who believe they were misled will likely be invited to join the action on a 'no risk basis' as costs will likely be borne by a litigation funder such as IMF Bentham Ltd (ASX: IMF).

However, before retail investors get too excited about the prospect of compensation it's worth noting the compensation available (if successful) will be rather small – it will likely be based on a percentage of losses incurred on shares bought at inflated prices over the period in question from when they purchased shares.

The real winners will be the fee-hungry lawyers as the net compensation available to investors will be after the litigation funder has taken a hefty percentage of total compensation awarded and paid Maurice Blackburn its own whopping fees.

In fact class actions have long been a gravy train for fee-gouging lawyers, with Maurice Blackburn also lining up class actions against Cash Converters Ltd (ASX: CCV), Vocation Ltd (ASX: VET) and Treasury Wine Estates Ltd (ASX: TWE) in 2015.

If an adverse ruling were issued against Slater & Gordon or if it were to settle with the litigants over the profit downgrade it would likely face a large one-off compensation bill.

The law firm will likely contest the action however and any compensation bill around the profit downgrade is unlikely to be so large as to have a disastrous impact given the precipitous falls in the share price after August 28 and November 30.

Motley Fool contributor Tom Richardson owns shares of Slater & Gordon Limited. You can find Tom on Twitter @tommyr345 Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »